Health & Life Co., Ltd. (TPEX:1781)
10.75
-0.10 (-0.92%)
Aug 26, 2026, 1:30 PM CST
Health & Life Revenue
Health & Life had revenue of 96.32M TWD in the quarter ending June 30, 2026, with 39.27% growth. This brings the company's revenue in the last twelve months to 400.09M, down -30.90% year-over-year. In the year 2025, Health & Life had annual revenue of 398.05M, down -43.65%.
Revenue (ttm)
400.09M
Revenue Growth
-30.90%
P/S Ratio
1.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
514.37M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 398.05M | -308.34M | -43.65% |
| Dec 31, 2024 | 706.39M | 105.22M | 17.50% |
| Dec 31, 2023 | 601.17M | -196.37M | -24.62% |
| Dec 31, 2022 | 797.54M | -14.34M | -1.77% |
| Dec 31, 2021 | 811.88M | 37.72M | 4.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 2.86B |
| Diamond Biotechnology | 464.63M |
| EPS Bio Technology | 418.74M |
| Radiant Innovation | 409.16M |
| Wiltrom | 314.09M |
| Taiwan Advanced Nanotech | 170.57M |
| PlexBio | 137.57M |
| AmCad BioMed | 28.60M |